Route 92 Reperfusion System for Acute Ischemic Stroke
The Route 92 HiPoint 88 aspiration system is a reasonable endovascular technique for reperfusion in adults with acute ischemic stroke due to ICA or M1 large-vessel occlusion within 8 hours, though stent retrievers remain the first-line recommendation based on Class I evidence from major guidelines.
Evidence-Based Framework
Guideline-Directed First-Line Approach
The 2015 AHA/ASA guidelines establish stent retrievers as Class I, Level A evidence for mechanical thrombectomy in patients meeting specific criteria 1. The guidelines explicitly state that "use of stent retrievers is indicated in preference to the MERCI device" and that "mechanical thrombectomy devices other than stent retrievers may be reasonable in some circumstances (Class IIb, Level B-NR)" 1.
The 2018 AHA/ASA update reinforces this hierarchy, noting that while aspiration techniques may be reasonable alternatives, stent retrievers remain the first choice 2.
Route 92 System Performance Data
Recent meta-analysis data (2026) demonstrates the Route 92 super large-bore (0.088") aspiration system achieves 3:
- First-pass effect (FPE): 56% in single-arm analysis
- Risk difference of +0.18 for FPE compared to other techniques (NNT = 6, p = 0.001)
- Near-complete to complete reperfusion: 94%
- Functional independence (mRS 0-2): 43%
- Symptomatic ICH: 3%
- Mortality: 20%
The comparative analysis showed significantly higher FPE rates and near-complete reperfusion (RD: 0.23, NNT = 4, p = 0.0005) versus other techniques 3.
Direct Aspiration vs. Stent Retriever Evidence
The 2024 ESO/ESMINT guideline for basilar artery occlusion suggests direct aspiration over stent retriever as first-line strategy (weak recommendation, very low quality evidence) 4. However, this is specific to posterior circulation and represents weaker evidence than the anterior circulation guidelines.
The ASTER trial found no significant difference between contact aspiration and stent retrievers for anterior circulation LVO: successful revascularization was 85.4% vs 83.1% (OR 1.20, p=0.53), and mRS 0-2 at 90 days was 45.3% vs 50.0% (OR 0.83, p=0.38) 2.
Practical Treatment Algorithm
Patient Selection Criteria (Within 8 Hours)
- Age ≥18 years
- Prestroke mRS 0-1
- ICA or M1 occlusion confirmed on CTA
- NIHSS ≥6
- ASPECTS ≥6
- No contraindication to IV alteplase (give if eligible) 1
Technical Approach
Start with stent retriever as guideline-recommended first-line device 1, 2
Consider Route 92 aspiration system as:
- Alternative first-line approach (Class IIb evidence level)
- Adjunctive technique with stent retriever
- Rescue strategy after failed stent retriever attempt
Use proximal balloon guide catheter or large-bore distal-access catheter in conjunction with chosen device (Class IIa) 1
Target TICI 2b/3 reperfusion as technical goal 1
Time-Dependent Considerations
- 0-6 hours: Class I evidence for EVT with stent retrievers 1
- 6-8 hours: Class IIb evidence (uncertain effectiveness) for ICA/M1 occlusion 1
- Beyond 6 hours: Consider advanced imaging (perfusion/DWI) to identify salvageable tissue 5, 6
Critical Caveats
Time is brain: Every 30-minute delay decreases good functional outcome by 8-14% 7. Do not delay treatment to debate device selection.
Do not wait to assess IV tPA response before proceeding to EVT 1. Eligible patients should receive IV alteplase even if mechanical thrombectomy is planned.
Intracranial atherosclerotic disease (ICAD): If underlying stenosis is discovered during procedure, the Route 92's large-bore aspiration may be less effective than angioplasty/stenting for ICAD-related occlusions 8, 9. Watch for guidewire behavior, residual stenosis after recanalization, and early reocclusion as clues to ICAD 8.
Device selection should not override speed: The Route 92 system's high first-pass effect rates (56% vs lower rates with other devices) may justify its use when operators are experienced with the system, as first-pass success correlates with better outcomes 3.
Bottom Line
While the Route 92 aspiration system shows promising performance data with high first-pass effect and reperfusion rates, stent retrievers maintain Class I guideline support as the primary mechanical thrombectomy device. The Route 92 is reasonable as an alternative first-line approach (Class IIb level), particularly when combined with proximal flow control, or as part of a combined technique strategy. The priority is achieving rapid TICI 2b/3 reperfusion—device choice matters less than speed and operator expertise 1, 2, 3.